NantKwest Культура компании

Dr. Barry J. Simon, M.D., has been President and Executive Director of NantKwest, Inc. since 2007 and has been its Chief Administrative Officer since January 2017. Dr. Simon served as Chief Operating Officer at NantKwest, Inc. since March 2015 until December 2016. Dr. Simon served as Chief Executive Officer of NantKwest, Inc. from 2007 to March 2015. Dr. Simon served as Vice President of Clinical and Regulatory affairs at itherX Pharmaceuticals, Inc. since June 2005. Dr. Simon joined Immusol over 20 years of strong scientific and clinical experience in infectious diseases, anesthesiology, oncology, dermatology and virology, having served in numerous commercial and drug development roles at organizations, such as Roche Labs, Inc. and F. Hoffman La Roche, (Nutley, New Jersey); Connetics Corporation (Palo Alto, CA); NorthSound Capital, LLC, HealthPro BioVentures and Immunomedics, Inc. (Morris Plains, New Jersey). Additionally he has served at the Albert Einstein College of Medicine (New York, New York), The Mount Sinai Medical Center (New York, New York), and The New York Infirmary (New York, New York). Dr. Simon is a co-founder of 2 biotechnology companies and had been an independent pharmaceutical consultant, advising clients regarding product licensing and commercialization initiatives. He has been a Director of Cue Biopharma, Inc. since March 2016 and Conkwest, Inc. Dr. Simon received his MD from SUNY Downstate/Health Sciences Center in Brooklyn, New York and was a Summa Cum Laude graduate of Hofstra University in Hempstead, New York. He attended corporate training programs by the London School of Business and the Amos Tuck School of Business at Dartmouth College. He trained clinically in infectious diseases, anesthesiology and internal medicine.

Mr. David J. Pyrce, M.B.A., has been the Chief Commercial Officer and Senior Vice President of Innovation & Investor Relations at NantKwest, Inc. since January 10, 2017. Mr. Pyrce served as Chief Business Officer at Pathway Genomics Corporation. Mr. Pyrce served as President at Bear Creek Capital Management. He served as Senior Vice President of Strategic Initiatives at NantHealth. He was at Vical Incorporated, which he joined in October 2001 as Vice President, Business Development. In addition, he served as Vice President and Senior Healthcare Analyst at First Security, Van Kasper & Company from 1993 to 1997 and as Vice President, Corporate Communications and Investor Relations, at Imagyn Medical Technologies from 1997 to 1999. A serial entrepreneur, Mr. Pyrce founded three companies, all with successful exits. He served as Research Analyst at Van Kasper & Co., Research Division. He has been involved in the business and investment side of the life sciences industry for over 25 years, with the last 10 years focused on genomics-based therapeutics and diagnostics. He served as an Equity Analyst at Wells Fargo Securities, LLC, Research Division. Mr. Pyrce has managed over 100 transactions, in equity and debt capital from strategic and financial partners. He served as Vice President of Diagnostic Products for Glyko Biomedical, Inc., from 1991 to 1993 and Director of Business Development at SmithKline Beecham from 1986 to 1991. From 1979 to 1986, he advanced through several sales and marketing positions at Baxter Healthcare, lastly as Vice President of Sales and Marketing. Mr. Pyrce received an M.B.A. in Financial Management and an M.S. in Financial Markets and Trading from the Stuart School of Business at the Illinois Institute of Technology in 1984. He received a B.S. degree in Biochemistry and Molecular Biology from Northern Illinois University in 1978. He is also an alumnus of the Advanced Executive Program at the Kellogg School of Business at Northwestern University.

Ms. Sonja Nelson has been the Chief Accounting Officer of NantKwest, Inc. since May 2016. Mrs. Nelson served as Vice President and Corporate Controller of NantKwest, Inc. Mrs. Nelson joined NantKwest in 2015. Mrs. Nelson served as Vice President & Corporate Controller at AltheaDx, Inc. since 2014 and as Senior Director & Controller at Cadence Pharmaceuticals, Inc (former NASDAQ: CADX). from 2012to 2014. Prior to that, Mrs. Nelson served as Director, General Accounting at Cricket Communications, Inc. (former NASDAQ: LEAP), a $3 billion wireless services provider, between 2008 and 2012. Mrs. Nelson started her career at KPMG, holds a Bachelor's degree in accounting and taxation from the University of Applied Sciences in Pforzheim, Germany and is a Certified Public Accountant.

Mr. Richard J. Tajak, M.B.A. has been an Interim Chief Financial Officer at NantKwest, Inc since January 20, 2016. Mr. Tajak has been Chief Financial Officer of ConjuChem, LLC since July 2011. He has been Chief Financial Officer of NantPharma, LLC since January 2014 and as Chief Operating Officer since June 2014. From July 2011 to December 2013, Mr. Tajak served as Chief Financial Officer of NantWorks, LLC. Mr. Tajak served Chief Financial Officer and Executive Vice President of Fresenius Kabi Pharmaceuticals Holding Inc. since April 29, 2008 and also served as its Principal Accounting Officer. Mr. Tajak served as Chief Financial Officer and Executive Vice President of Fresenius Kabi USA, LLC since April 29, 2008. Mr. Tajak served as a Senior Vice President of Finance at Fresenius Kabi USA, LLC since March 2008. He served as Executive Vice President and Chief Financial Officer for APP Pharmaceuticals, Inc from April 2008 to June 2011 and served as its Senior Vice President, Finance since March 2008. He has over 25 years of broad and extensive pharmaceutical experience. Mr. Tajak held the position of Senior Vice President of Finance and Treasurer, was an officer of Astellas Pharmaceuticals, Inc.' U.S. and Canadian operations, President of Astellas' captive insurance company. Mr. Tajak served for Fujisawa Healthcare/USA and Lyphomed Inc., where he had increasing levels of responsibility in the areas of accounting, finance, SEC reporting, audit and corporate operations. Mr. Tajak holds a Bachelors degree in Finance and an M.B.A from the University of Notre Dame and is a Certified Public Accountant.

John Lee serves as the Senior Vice President of NantKwest. John started at NantKwest in May of 2016. John currently resides in Greater Los Angeles Area.

James Tzavaras serves as the VP, Financial Planning & Analysis of NantKwest. James started at NantKwest in December of 2015. James currently resides in Greater San Diego Area.

David Pyrce serves as the Senior Vice President, Innovation & Chief Commercial Officer of NantKwest. David currently resides in the Greater San Diego Area.

Connie Chang serves as the Vice President of Quality, Process Control & Tech Transfer of NantKwest. Connie currently resides in the Greater Los Angeles Area.